Diphenylethylene compounds for treating diabetes and related conditions

摘要

Diphenylethylene compounds that can be administered orally to decrease circulating concentrations of glucose are disclosed. These compounds are orally effective anti-diabetic agents that may normalize glucose and lipid metabolism in subjects with diabetes. The effect on insulin resistant rats is also shown. The effects on lipid and leptin concentrations are also shown.